TrialBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2024

Safety of a 90-min duration of intravenous infusion of obinutuzumab in patients with B-cell non-Hodgkin's lymphoma in a tertiary hospital in China: a prospective, open-label, exploratory clinical trial.

Shuangshuang Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.